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The inhibitory properties of Methanolic leaf extract of Hibiscus 
cannabinus (Malvaceae family) on glycosylation formation, was 
investigated in haemoglobin using Gallic acid as Standard. The 
periodic glycosylation of haemoglobin at varying concentration of 
glucose shows a decrease in haemoglobin concentration indicating 
the glycosylation of haemoglobin. While the subsequent 
administration of Hibiscus cannabinus Methanolic leaf extract inhibit 
haemoglobin glycosylation, where a concentration of 20 mg/ml of the 
extract gave a significant inhibition by yielding haemoglobin 
concentration of 1.877±0.40 µg/ml for test extract as against 
0.032±0.013 µg/ml for the standard. This suggests that the plant 
extract inhibits the binding of glucose to hemoglobin, since at higher 
concentration of glucose the concentration was found to be high.  
 




Glucose reacts nonenzymatically with proteins in vivo, chemically 
forming covalently attached glucose-addition products and cross-
links between proteins. The excessive accumulation of rearranged 
late-glucose-addition products, or advanced glycosylation end 
products (AGEs), is believed to contribute to the chronic 
complications of diabetes mellitus (Makita et al., 1991).  
 
Apart from protein (enzymes) that enhances glycosylation, 
nonenzymatic glycosylation also occur in nucleic acids. In the later 
reaction, reversible Schiff base and Amadori product are form in 
proportion to glucose concentration. Equilibrium is reached after 
several weeks and further accumulation of these nonenzymatic 
glycosylation products ceases. Subsequent reactions of the 
Amadori product slowly give rise to nonequilibrium advanced 
glycosylation end-products which continue to accumulate 
indefinitely on longer-lived molecules. Excessive formation of both 
types of nonenzymatic glycosylation product appears to be the 
common biochemical link between chronic hyperglycemia and a 
number of pathophysiologic processes potentially involved in the 
development of long-term diabetic complications (that affect the 
eyes, kidneys, and nerves). The major biological effects of 
excessive nonenzymatic glycosylation include: inactivation of 
enzymes; inhibition of regulatory molecule binding; crosslinking of 
glycosylated proteins and trapping of soluble proteins by 
glycosylated extracellular matrix (both may progress in the 
absence of glucose); decreased susceptibility to proteolysis; 
abnormalities of nucleic acid function; altered macromolecular 
recognition and endocytosis; and increased immunogenicity 
(Brownlee et al., 1984). 
 
The normal level for glycosylated hemoglobin is less than 7%. 
Diabetics rarely achieve such levels, but tight control aims to come 
close to it. Levels above 9% show poor control, and levels above 
12% show very poor control. It is commonly recommended that 
glycosylated hemoglobin should be measured every 3 to 6 months  
 
in persons suffering from diabetes. Since the glucose stays 
attached to hemoglobin for the life of the red blood cell (normally 
about 120 days), the level of glycosylated hemoglobin reflects the 
average blood glucose level over the past 3 months (Medicine Net. 
Com, 2010), hence the inhibition of the glycosylation processes 
may abate the complication seen diabetic individuals.  
 
Natural plant product have shown great potential in the 
management of various ailment and Hibiscus cannabinus L. 
(Malvaceae) is one of such plant that has long been used as folk 
medicine in India and Africa for the treatment of various disease 
conditions (Duke, 1983). The plant is commonly known as Rama in 
northern Nigeria, where it is used as vegetables in the preparation 
of local dish called ‘pate’ (i.e. maize portage) and the preparation 
of a local salad. Audu (1989) indicated that H. cannabinus in 
combination with Leptadenia hastata is used as an anti-diabetic 
remedy in Bauchi State, Nigeria. 
 
Since glycosylation reaction involves the formation of reactive 
oxygen species, natural plant products may likely inhibit advanced 
glycosylation end products (AGEs) (Adisa et al., 2004). Studies 
conducted by James et al., (2010), Agbor et al., (2005) and 
Ibrahim et al., (2005) all implicated the plant H. cannabinus to have 
glycosides such as flavonoids and Anthroquinone in addition to 
possessing antioxidant activity. This study is aimed at ascertaining 
the glycosylation inhibitory effect of the Methanolic leaf extract of 
H. cannabinus, as a co-adjuvant in the management of diabetics 
mellitus complication. 
 
MATERIALS AND METHODS 
Reagents: All chemicals and reagents used for the study were of 
analytical grade. 
 
Plant material: The leaves of Hibiscus cannabinus were collected 
from four different communities around Kaduna State, Nigeria 
between the months of July and August, 2009 and authenticated 
by the Department of Biological Sciences, Kaduna State 
University, Kaduna, Nigeria.  
 
Fresh leaves were collected and dried for four days, crushed to 
powder and stored in an airtight container at 25oC. 
  
Extraction: The powdered plant material (50g) was soaked in 
methanol and stirred (with the aid of a magnetic stirrer) for one 
hour, then stored in the dark for 48 hours after which the mixture 
was filtered first with muslin then filtered again with cotton wool in 
funnel. The filtrate was then evaporated with the aid of rotary 
evaporator. 
 
Blood sample collection and preparation of haemoglobin: 
Blood sample were collected by venopuncture via the cubital vein. 
Four New Zealand breed of rabbits were placed on the working 
bench and their fore limb were shave around the cubital area. With 
the on a pressure around the cubital area the cubital vein was 
located, the area disinfected with alcohol and with the aid of 
syringe and needle 30ml of blood was withdrawn and transferred 
into a blood bottle containing Ethylene diamine  tetraacetic acid 
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Haemolysate was prepared following Asgary et al., (1999) as 
reported by Adisa et al. (2004) based on the principle of hypotonic 
lysis. From the procedure, the red blood collected were washed 
thrice with 0.14M NaCl solution and 1 volume of red blood cells 
suspension was lysed with 2 volume of 0.01M phosphate buffer, 
pH 7.4 and 0.5 volume of carbon tetrachloride. The haemolysate 
was then freed from the debris by centrifugation at 2300 rpm for 15 
min at room temperature. The haemoglobin rich fraction (upper 
layer) was separated and dispensed into sample bottle for storage 
in the refrigerator until required for use. 
 
Estimation of haemoglobin concentration: The haemoglobin 
concentrations were estimated by Drabkin & Austin (1932) 
method. Into test tube 20 µl of blood and standard solution were 
transferred into their respective tubes. To each tube 5 ml of 
Drabkin’s reagent was added, mixed properly and was allowed to 
stand for 10 min. The absorbance for the test and standard 
solution were read at 540 nm and the haemoglobin concentration 
determined (Raphael, 1983). 
 
Estimation of haemoglobin glycosylation: Non-enzymic 
glycosylation of haemoglobin was estimated by Parker et al., 
(1981) modification as reported by Adisa et al., (2004). Into three 
test tubes each containing 1 ml solution of different concentration 
(2, 10, and 20 mg/ml) of glucose in 0.01M phosphate buffer pH 
7.4, 1 ml each of haemoglobin fraction was transferred. The 
contents were incubated at room temperature for 72 hrs. A blank 
solution in which the addition of glucose solution was omitted was 
used as control. The amounts of hydroxymethylfurfural in 
nanomole released were estimated at different incubation periods 
of 0, 24hrs, 48hrs and 72hrs which corresponds to the degree of 
glycosylation. 
 
Effect of Extract on Haemoglobin Glycosylation: To 1 ml of 
haemoglobin solution 5µl of gentamycin and 25µl of Gallic acid (as 
standard) 25 µl of the leave extract of H. cannabinus was added. 
The reaction was started by the addition of 1 ml of 2% glucose in 
0.01M phosphate buffer pH 7.4 and incubated in the dark at room 
temperature. The concentrations of glycated haemoglobin at the 
incubation period of 0, 24 and 72 hrs were estimated 
colorimetrically at 443 nm (Adisa et al., 2004). The test was 
conducted in triplicate.  
 
Effect of extract at physiological glucose concentration:To 1 
ml of haemoglobin solution, 1 ml of glucose solution and 5µl of 
gentamycin in 0.01M phosphate buffer pH 7.4 were mixed and 
incubated in the dark at room temperature in the presence or 
absence of 10µg, 20µg or 30 µg/ml of Gallic acid or H. 
cannabinus extract respectively. Different concentration of glucose 
1mg, 2mg, 4mg, 6mg, 8mg 10mg, 15mg and 20mg in 20 ml each 
of 0.01M phosphate buffer, pH 7.4 were used. Haemoglobin 
concentrations were estimated daily throughout the incubation 
period (72hrs) as an index for measuring the degree of 
haemoglobin glycosylation; the absorbance reading read 
colorimetrically at 443 nm. The assay was carried out in triplicates 
(Adisa et al., 2004). 
 
RESULTS  
The exposure of haemoglobin over a period of 72 hours to varying 
concentration of glucose (2mg, 10mg and 20mg) showed decrease 
in the concentration of haemoglobin indicating an increase in the 
glycosylation of hemoglobin (Table 1). While Table 2 indicate the 
inhibition of glycosylation of hemoglobin as compared between the 
plant extract and a standard (Gallic acid). The Effect of H. 
cannabinus methanolic leaf extract at physiologic glucose.
TABLE 1. ESTIMATION OF HAEMOGLOBIN GLYCOSYLATION 
OVER THE PERIOD OF 72 HOURS 
 
 Glycosylated haemoglobin (nanomole of 
Hydroxymethyl furfural) 
Glucose 
concentration 24hrs 48hrs 72hrs 
2 mg/ml 0.846 ± 0.005 1.214 ± 0.006 0.405 ± 0.002 
10 mg/ml 0.736 ± 0.002 0.883 ± 0.008 0.07 ± 0.003 
20 mg/ml 0.920 ± 0.005 0.736 ± 0.009 0.368 ± 0.007 
 
TABLE 2.  EFFECT OF Hibiscus cannabinus LEAF EXTRACT ON HAEMOGLOBIN 
GLYCOSYLATION AS COMPARED WITH STANDARD (GALLIC ACID) 
 
 Glycosylated haemoglobin (nanomole of 
Hydroxymethyl furfural) 
Time 24hrs 48hrs 72hrs 
Extract (25 µl) 4.531 ± 0.00 1.288 ± 0.004 0.994 ± 0.004 
Gallic acid (25µl) - 1.104 ± 0.002 0.019 ± 0.007 
 
TABLE 3. EFFECT OF Hibiscus cannabinus METHANOLIC LEAVE EXTRACT AT 
PHYSIOLOGICAL GLUCOSE CONCENTRATION 
 
 Concentration of glycosylated haemoglobin (nanomole of 
Hydroxymethyl furfural) 
 Hibiscus cannabinus (µg/ml) Gallic acid (µg/ml) 
Gluc mg/ml 24hr 48hr 72hr 24hr 48hr 72hr 
1 0.730±0.013 0.810±0.00  1.619±0.01 1.614±0.014 2.252±0.014 2.331±0.003 
2 1.096±0.017 0.810±0.00 1.546±0.105 - - - 
4 0.626±0.00 1.178±0.00 1.509±0.130 - - - 
6 1.251±0.122 1.435±0.122 1.914±0.138 - - - 
8 0.405±0.00 1.067±0.339 1.472±0.224 - - - 
10 0.00±0.00 0.258±0.1.17 0.92±0.00 - - - 
15 0.00±0.00 0.810±0.00 0.920±0.202 - - - 
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concentration (Table 3), compared with the data for standard 
(1mg/ml and 20mg/ml), showed an increase in the concentration of 
hemoglobin over all the periods of incubation, indicating inhibition 
of glycosylation. In comparison with standard, at 1mg/ml the 
increase in hemoglobin concentration was higher than that of the 
plant extract, but at 20mg/ml the increase in hemoglobin 




This result suggests that the plant extract inhibits the binding of 
glucose to hemoglobin, since at higher concentration of glucose 
the concentration was found to be high.  
 
Literature has shown that AGEs is now known to be the source of 
free radicals in diabetes, thus aggravating the state of an 
increased oxidative stress in diabetes mellitus (Adisa et al., 2004), 
hindering its formation implies lower level of free radicals in 
diabetes, and reduced diabetic complication. 
 
In the management of diabetic in appropriate attention has been 
given to the reducing properties of monosaccharide. In addition to 
direct glycosylation reactions, monosaccharides can enolize and 
thereby reduce molecular oxygen under physiological conditions, 
yielding α-ketoaldehydes, H2O2 and free radical intermediates 
(Wolff & Dean, 1987). In vivo the occurrence of this process 
contributes to the elevated plasma peroxides found in diabetics 
complication and may contribute to protein modification reactions 
perform with glucose in vitro.  Thus with the high level of glucose in 
the blood, erythrocytes has become important in the 
pathophysiologic mechanisms in diabetics as shown from several 
abnormal features demonstrated for red cells of diabetes mellitus 
patients (Adisa et al., 2004). 
 
It is concluded that the administration of H. cannabinus methanolic 
leaf extract inhibits glycosylation of hemoglobin as such the 
formation of advance glycated end-product (AGEs) may be 
inhibited by the plant extract. This observed effect might be 
attributed by the presence of bioactive compounds in the plant 
extract like flavonoids, alkaloids, phenols and sterols. This needs 
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